(MENAFN- GlobeNewsWire - Nasdaq) The global Robotic Radiotherapy Market is experiencing strong growth as rising cancer incidence and precision-focused treatment systems transform oncology care. Advancements in real-time imaging, robotics, and AI are improving treatment accuracy and reducing patient side effects.

Austin, Texas, Dec. 05, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Robotic Radiotherapy Market Size was valued at USD 1.15 Billion in 2023 and is expected to reach USD 3.18 Billion by 2032 and grow at a CAGR of 12.02% over 2024-2032.

The market for robotic radiotherapy is growing as a result of technological advancements that provide more precise and effective cancer treatment. For instance, advancements in image-guided radiotherapy (IGRT) and perhaps even intensity-modulated radiation therapy (IMRT) have improved treatment results.

Get a Sample Report of Robotic Radiotherapy Market:

Major Companies in the Robotic Radiotherapy Market Include:

• Varian Medical Systems
• Elekta
• Accuray Incorporated
• Siemens Healthineers
• Philips Healthcare
• Hitachi Medical Systems
• C-RAD
• RaySearch Laboratories
• Brainlab
• MediTech
• Bluebird Bio
• Panasonic Healthcare
• GE Healthcare
• ViewRay
• Sordina I.P.S.
• United Imaging Healthcare
• Fujifilm Medical Systems
• CMS
• RayCare
• Civco Medical Solutions
• Other Participants

Robotic Radiotherapy Market Report Scope

Report Attributes	Details
Market Size in 2023	USD 1.15 Billion
Market Size by 2032	USD 3.18 Billion
CAGR	CAGR of 12.02% From 2024 to 2032
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020-2022
Key Segments	. by Product (Radiotherapy system, Software, 3D cameras, other) . by Technology (Linear Accelerators, Stereotactic Radiation Therapy, Particle Therapy) . by Application (Prostate Cancer, breast cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer, Other Cancer) . by End Use (Hospital, Independent Radiotherapy Centers)
Regional Analysis/Coverage	North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).

Revolutionizing Cancer Care Outpatient Treatment Models are Driving Market Growth

The market for robotic radiotherapy is expanding thanks to the outpatient treatment concept. As healthcare organizations strive to lower costs and increase patient comfort, outpatient radiation is a viable option. Similar to excision for atypical nevi, therapy can be done as an outpatient procedure, which eliminates the need for an overnight hospital stay and improves patient satisfaction and quality of life. This trend is noteworthy because it aims to assist healthcare providers in streamlining their facilities' operations and reducing the financial burden associated with inpatient care.

Integration Challenges in Robotic Radiotherapy Adoption for Enhanced Cancer Treatment May Limit Market Expansion Globally

One of the main obstacles facing the robotic radiotherapy market is the shortage of skilled operators for these complex robotic devices. Because these technologies are intricate and require specialized training, there is a mismatch between the growing need for robotic therapies and the available workforce. The widespread use of robotic radiation may be hampered by this issue, particularly in less developed or smaller healthcare facilities where it is difficult to recruit qualified staff.

For a Personalized Briefing with Our Industry Analysts, Connect Now:

Segmentation Analysis:

By Product

Software, which accounted for a 41% share in the Robotic Radiotherapy Market in 2023 due to its fundamental role in improving the efficiency and accuracy of radiotherapy therapies, is fueling growth in this sector. Radiotherapy systems are envisaged to witness the fastest CAGR between 2024 and 2032 owing to continuous technological developments and growing investment in robotic systems.

By Technology

Linear accelerators led the market in 2023 with 49% share and are projected to grow at the fastest CAGR during the period from 2024-2032. This dominance can be attributed to their successful track record in providing accurate and local treatment for different cancer patient cohorts.

By Application

In 2023, Lung cancer held the largest share at 36% in the Robotic Radiotherapy market and is projected to rise Furthermore, it is expected that over the forecast period of 2024-2032. The reason for this is dominant as lung cancer is one of the most frequently diagnosed cancers all over the world every year. The high prevalence of the disease with a substantial demand for effective treatment is attributed to possible risk factors including smoking, environmental contaminants, and genetic characteristics.

By End-Use

In 2023, hospitals dominated with a market share of 58% owing to their overall capabilities in advanced cancer care with access to sophisticated technology and multidisciplinary teams. Independent Radiotherapy Centers will grow at the fastest CAGR during 2024-2032. This growth is driven by the increasing demand for convenient and accessible cancer treatment centers.

Regional Insights:

North America held the largest share of 42% in terms of revenue in the Robotic Radiotherapy Market in 2023 and is expected to grow fastest during 2024-2032 at a higher CAGR. The dominance can be attributed to the well-established healthcare infrastructure in the region, high investments in medical technology as well as a large pool of cancer patients. In addition, continuous partnerships of technology provider companies and healthcare providers such as Varian Medical Systems along with key hospitals for clinical development and implementation of new robotic solutions are expected to drive market growth in North America.

Recent Developments:

• In June 2024, Apollo Cancer Centres launched advanced robotic radiotherapy using Accuray's CyberKnife System, offering precise and non-invasive treatment options for cancer patients. This partnership aims to enhance patient outcomes through cutting-edge technology.
• In June 2024, Researchers at King's College Hospital used a custom robot to deliver targeted radiation for treating wet age-related macular degeneration, enhancing standard eye treatment.

Purchase Single User PDF of Robotic Radiotherapy Market Report:

Exclusive Sections of the Report (The USPs):

• TREATMENT EFFICACY BENCHMARKS – helps you assess clinical performance by analyzing accuracy levels, treatment success rates, and consistency of outcomes across robotic radiotherapy systems.
• TRAINING & SKILL PROFICIENCY METRICS – helps you understand workforce readiness through evaluation of clinician training hours, certification levels, and adoption of advanced skill-development programs.
• TECHNOLOGY ADOPTION INDEX BY REGION – helps you identify regional disparities in robotic radiotherapy implementation, highlighting markets with high penetration versus emerging adoption hotspots.
• TIME & WORKFLOW EFFICIENCY SCORES – helps you measure improvements in treatment planning time, session duration, and overall patient throughput enabled by robotic radiotherapy systems.
• COMPETITIVE TECHNOLOGY LANDSCAPE – helps you compare leading vendors based on system capabilities, upgrade pathways, product innovations, and market expansion strategies.

Related Reports

Radiotherapy Market

Radiation Oncology Treatment Planning Software Market

Radiology Information Systems (RIS) Market

Cancer Diagnostics Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email:...

MENAFN05122025004107003653ID1110441599